ロード中...
Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention
Clinical trial data on selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) have demonstrated reduced breast cancer incidence in the prevention setting among high-risk women. We conducted an extensive review of clinical trials and recent published reports of barriers to upta...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3744245/ https://ncbi.nlm.nih.gov/pubmed/23956815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-012-0082-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|